AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
6
AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
6
AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
6
AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
6
AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024
View
Metabolism, Alcohol & Toxicity
6
AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging Disease-Specific Therapies - EASL Congress 2024
View
Liver Tumours
1
Norgine: An Ounce of Prevention is Worth a Pound of Care - ILC 2022
View
Liver Tumours
5
Boston Scientific: Radioembolisation in the BCLC and beyond: An MDT approach - Liver Cancer Summit 2022
View
Liver Tumours
5
Boston Scientific: Radioembolisation in the BCLC and beyond: An MDT approach - Liver Cancer Summit 2022
View
Liver Tumours
5
Boston Scientific: Radioembolisation in the BCLC and beyond: An MDT approach - Liver Cancer Summit 2022
View
Liver Tumours
5
Boston Scientific: Radioembolisation in the BCLC and beyond: An MDT approach - Liver Cancer Summit 2022
View
Liver Tumours
5
Boston Scientific: Radioembolisation in the BCLC and beyond: An MDT approach - Liver Cancer Summit 2022
